Stay updated on CTLA4-NF, Nivolumab, Radiation in Metastatic Malignancies Clinical Trial
Sign up to get notified when there's something new on the CTLA4-NF, Nivolumab, Radiation in Metastatic Malignancies Clinical Trial page.

Latest updates to the CTLA4-NF, Nivolumab, Radiation in Metastatic Malignancies Clinical Trial page
- Check2 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check9 days agoChange DetectedThe study record now indicates that results have been submitted, replacing the previous notice that no results were posted.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe study record history shows a new revision entry labeled v3.7.0, replacing the previous revision v3.6.6. This update reflects a metadata change to the record's revision history rather than to the study data itself.SummaryDifference0.1%

- Check44 days agoChange DetectedThe page's Version History shows a new revision: v3.6.6 replaces the previous v3.6.5, representing a small update to the page’s versioning metadata.SummaryDifference0.1%

- Check66 days agoChange DetectedA new revision entry v3.6.5 was added to the record history, indicating an update to the page’s version history. The previous v3.6.4 entry was removed from the history.SummaryDifference0.1%

- Check80 days agoChange DetectedA new revision entry (v3.6.4) was added to the study record history, and the previous revision (v3.6.3) was removed. This reflects an administrative update to the record rather than changes to the study data.SummaryDifference0.1%

Stay in the know with updates to CTLA4-NF, Nivolumab, Radiation in Metastatic Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CTLA4-NF, Nivolumab, Radiation in Metastatic Malignancies Clinical Trial page.